Clinical Trails of Photoelectrochemical Immunosensor for Early Diagnosis of Acute Myocardial Infarction

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04390490

Enrollment

100

Registered

2020-05-15

Start date

2020-10-01

Completion date

2023-12-01

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Brief summary

The aim of this prospective randomized controlled clinical trial will evaluate the sensitivity, precision and effectiveness of photoelectrochemical immunosensor for early diagosis of acute myocardial infarction.

Interventions

DEVICEGraphene quantum dots combined with Si nanowire photoelectrochemical immunosensor

Graphene quantum dots combined with Si nanowire is a new method of photoelectrochemical immunosensor

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Age \> 18 years * Symptoms of chest pain

Exclusion criteria

* Patients who will undergo immediate PCI Pregnant * Lactating women * Patients with mental disorders * Patients are using other experimental drugs; Refusal to provide informed.

Design outcomes

Primary

Measure	Time frame	Description
Effectiveness of photoelectrochemical immunosensor	28 days	Sensitivity，precision and cost of the photoeletrochemical immunosensor

Countries

China

Contacts

Primary ContactBin He, PhD

hebinicu@139.com021-25077828

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026